CNAT - Conatus Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $-10.1. This is a potential upside of $-10.1 (0%) from yesterday's end of day stock price of $0.

Conatus Pharmaceuticals's activity chart (see below) currently has 0 price targets and 3 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 208.5 days.

Most recent stock forecast was given by ED ARCE from HC WAINWRIGHT on 22-Mar-2019. First documented stock forecast 22-Sep-2015.

Best performing analysts who are covering CNAT - Conatus Pharmaceuticals:

Ed Arce Stephen Willey

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$8

$7.44 (1328.57%)

$8

6 years 7 months 3 days ago
(22-Mar-2019)

7/7 (100%)

$-4.8 (-37.50%)

216

Buy

$4

$3.44 (614.29%)

6 years 10 months 19 days ago
(06-Dec-2018)

1/1 (100%)

$-15.4 (-79.38%)

201

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CNAT (Conatus Pharmaceuticals) average time for price targets to be met?

On average it took 208.5 days on average for the stock forecasts to be realized with a an average price target met ratio 100

Which analyst has the current highest performing score on CNAT (Conatus Pharmaceuticals) with a proven track record?

ED ARCE

Which analyst has the current lower performing score on CNAT (Conatus Pharmaceuticals) with a proven track record?

STEPHEN WILLEY

Which analyst has the most public recommendations on CNAT (Conatus Pharmaceuticals)?

Ed Arce works at WESTPARK and has 12 price targets and 8 ratings on CNAT

Which analyst is the currently most bullish on CNAT (Conatus Pharmaceuticals)?

Ed Arce with highest potential upside - $7.44

Which analyst is the currently most reserved on CNAT (Conatus Pharmaceuticals)?

Stephen Willey with lowest potential downside - $3.44

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?